Brief: Longeveron Announces New Long-Term Survival Data From Elpis I Trial Of Lomecel-B For Hypoplastic Left Heart Syndrome
09/05/2023 14:09
May 9 (Reuters) - Longeveron Inc LGVN.O :
* LONGEVERON ANNOUNCES NEW LONG-TERM SURVIVAL DATA FROM
ELPIS I
TRIAL OF LOMECEL-B™ FOR HYPOPLASTIC LEFT HEART SYNDROME
* LONGEVERON INC - ENROLLMENT ONGOING IN PHASE 2A ELPIS II
TRIAL
* LONGEVERON INC - DATA REINFORCE POTENTIAL SURVIVAL BENEFIT
OF
LOMECEL-B(TM) FOR PATIENTS WITH HYPOPLASTIC LEFT HEART SYNDROME
Source text for Eikon: ID:nGNXbjjdrf
Further company coverage: LGVN.O
((Reuters.Brief@thomsonreuters.com;))